CD274 and neoplasm: Subgroup analysis suggested that patients with PD-L1-negative tumors had a significantly longer PFS and OS, indicating that radiation may alter the tumor microenvironment of PD-L1-negative tumors, thereby facilitating the effects of pembrolizumab (23).